Dr. James Sinclair, MD
9850 Genesee Ave Ste 560, LA Jolla, CA 92037 • +1-775-555-7618
Medical Education: Accredited U.S. Medical School (Class of 2016)
What This Doctor Actually Performs: CMS Medicare Utilization & LA Jolla Percentiles
NPI #1356300230 • CBSA Regional • Hematology-Oncology
Dr. James Sinclair, MD (NPI #1356300230) practices Hematology-Oncology in LA Jolla, CA (92037) with sub-specialty concentration in 141 Active CMS HCPCS Codes, recording 164,352 annual CMS services across 568 distinct beneficiaries—placing this practice as a upper-quartile active clinical volume (71.43th LA Jolla percentile) (+1.10σ vs CA state mean, 89.05th statewide percentile).
Procedural volume for Dr. Sinclair is led by HCPCS 99214 (Moderate-to-High Complexity Internal Medicine Follow-Up — 3066 annual services, $50–$68 GPCI cash estimate), followed by CPT 99213 (Established Preventive & Chronic Care Visit, 1771/yr) and CPT 93000 (In-Office 12-Lead Resting Electrocardiogram, 886/yr).
Self-pay new patient consultations with Dr. Sinclair (CPT 99204 GPCI-adjusted benchmark) estimate around $239.00 (community reported average: $239.00) with in-person clinic visits only, 20-minute average reception wait, and a 4.50/5 modern protocol openness score across 24 patient logs.
Clinical background for Dr. Sinclair (MD, NPI #1356300230) includes accredited doctoral training (2016, 10 yrs in practice) and dedicated on-site consultations at 9850 Genesee Ave Ste 560.
Compared against LA Jolla, CA Hematology-Oncology peers
164,352 annual services across 568 beneficiaries
Standard deviations from CA Hematology-Oncology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Moderate-to-High Complexity Internal Medicine Follow-Up | 3,066 | 71.43th | $50 – $68 |
| 99213 | Established Preventive & Chronic Care Visit | 1,771 | 68.43th | $38 – $53 |
| 93000 | In-Office 12-Lead Resting Electrocardiogram | 886 | 74.43th | $25 – $40 |
| G0439 | Annual Preventive Wellness & Cardiometabolic Risk Assessment | 681 | 76.43th | $58 – $80 |
| 99204 | Comprehensive New Patient Internal Medicine Diagnostic Visit | 409 | 68.43th | $69 – $94 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (141 HCPCS billing breadth) | 157,539 | 71.43th | $45 – $65 |
Are you Dr. James Sinclair? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in LA Jolla, CA:
<a href="https://dotmd.com/doctors/james-sinclair-md-la-jolla-ca-1356300230" title="Dr. James Sinclair, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1356300230.svg" alt="Dr. James Sinclair Hematology-Oncology Badge" width="280" height="72" /></a>
Dr. James Sinclair, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Sinclair National Provider Identifier | NPI #1356300230 (MD) | CMS NPPES Registry (92037) |
| Dr. Sinclair LA Jolla CMS Volume Rank | 71.43th Pct (164,352 CMS svcs; Z +1.102σ) | CMS Medicare Part B (CA Hematology-Oncology) |
| Fair Cash-Pay New-Patient Benchmark | $239.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (LA Jolla, CA) |
| Waiting-Room Wait Time & Cash Friendliness | $239.00 avg paid • 20 min lobby wait | 24 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.75/5 Listening • 4.50/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. James Sinclair
Other High-Volume Hematology-Oncology Specialists in LA Jolla, CA
Ranked strictly by CMS Medicare volumeDr. Sinclair Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in LA Jolla, CA.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. James Sinclair community threads and patient logs by age, biological sex, dosage, and treatment duration.